Inventor
WILDE VICTORIA LYNN
US8 patents
Patents
8 patentsUS10239864B2Mar 26, 2019
2-H-indazole derivatives as cyclin-dependent kinase (CDK) inhibitors and therapeutic uses thereof
BETA PHARMA INC5 citations81
US9878994B2Jan 30, 2018
2-H-indazole derivatives as cyclin-dependent kinase (CDK) inhibitors and therapeutic uses thereof
BETA PHARMA INC8 citations81
US10590111B2Mar 17, 2020
Substituted 2-anilinopyrimidine derivatives as EGFR modulators
BETA PHARMA INC2 citations70
US12187707B2Jan 7, 2025
Pharmaceutical formulations of N-(2-(2-(dimethylamino)ethoxy)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylaminde and salts thereof
BETA PHARMA INC0 citations59
US11414401B2Aug 16, 2022
Substituted 2-anilinopyrimidine derivatives as EGFR modulators
BETA PHARMA INC0 citations59
US11180478B2Nov 23, 2021
Pharmaceutical formulations of N-(2-(2-(dimethylamino) ethoxy)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide and salts thereof
BETA PHARMA INC0 citations59
US11052086B2Jul 6, 2021
2-anilinopyrimidine derivatives as therapeutic agents for treatment of brain cancers
BETA PHARMA INC0 citations59
US10844045B2Nov 24, 2020
Pharmaceutical salts N-(2-(2-(dimethylamino)ethoxy)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide and crystalline forms thereof
BETA PHARMA INC0 citations50